Intratumoral and Subcutaneous Injection of HVJ‐E (GEN0101) in Metastatic Castration‐resistant Prostate Cancer

Cancer Science - United States
doi 10.1111/cas.14366
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Phase I/Ii Clinical Trial to Assess Safety and Efficacy of Intratumoral and Subcutaneous Injection of HVJ-E in Castration-Resistant Prostate Cancer Patients

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2017English

Patient Reported Outcomes in Metastatic Castration-Resistant Prostate Cancer

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Metastatic Castration-Resistant Prostate Cancer: Critical Review of Enzalutamide

Clinical Medicine Insights: Oncology
Oncology
2013English

Pcn346 - Disease Specific Cost Analysis of the Nonmetastatic Castration-Resistant Prostate Cancer and Metastatic Castration-Resistant Prostate Cancer Health States

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Metastatic Castration-Resistant Prostate Cancer: The Emerging Continuum of Care

Journal of the Canadian Urological Association
OncologyUrology
2013English

Prostate-Specific Membrane Antigen–Directed Therapy for Metastatic Castration-Resistant Prostate Cancer

Cancer Journal
Cancer ResearchOncology
2016English

Resistance to Novel Antiandrogen Therapies in Metastatic Castration-Resistant Prostate Cancer

Clinical Medicine Insights: Oncology
Oncology
2016English

BRD4 Regulates Metastatic Potential of Castration-Resistant Prostate Cancer Through AHNAK

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2019English

The Contemporary Use of Radium-223 in Metastatic Castration Resistant Prostate Cancer

Clinical Genitourinary Cancer
OncologyUrology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy